{"id":36699,"date":"2015-09-08T08:34:09","date_gmt":"2015-09-08T12:34:09","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=36699"},"modified":"2015-09-08T08:34:09","modified_gmt":"2015-09-08T12:34:09","slug":"pharmacyte-biotech-inc-otcmktspmcb-and-growblox-sciences-inc-otcmktsgblx-trades-in-a-narrow-range","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-and-growblox-sciences-inc-otcmktsgblx-trades-in-a-narrow-range-36699","title":{"rendered":"Pharmacyte Biotech Inc (OTCMKTS:PMCB) And Growblox Sciences Inc (OTCMKTS:GBLX) Trades In A Narrow Range"},"content":{"rendered":"<p style=\"text-align: justify;\"><strong>Pharmacyte Biotech Inc (OTCMKTS:PMCB)<\/strong> declined 0.52% and closed at $0.0959 in last trading session. The biotech firm is still in clinical stage and it is working to develop targeted therapies to treat diabetes and cancer based on Cell-in-a-Box\u00ae technology. Recently, the COO of Pharmacyte, Dr. Gerald W. Crabtree, Ph.D. highlighted company\u2019s development plans in an interview featured in \u2018PharmaVOICE Magazine\u2019.<\/p>\n<p style=\"text-align: justify;\">Dr. Crabtree stated that that the company has engaged leading expert team for the advancement of advanced therapies. The expert team will help company to move forward with the planned clinical development trials. This interview with PharmaVOICE magazine worked as an opportunity for the management to highlight the development plans and reason behind deploying the expert team.<\/p>\n<p style=\"text-align: justify;\"><strong>Growblox Sciences Inc (OTCMKTS:GBLX)<\/strong> a BioPharma firm with state-of-the-art technologies in plant biology developed to cultivate medicinal cannabis, <a href=\"http:\/\/finance.yahoo.com\/news\/growblox-sciences-appoints-cfo-john-123000923.html\">stated<\/a> that the company engaged Mr. John Poss as the new CFO. Craig Ellins, the CEO expressed that the performance of Poss as a consultant in the company encouraged them to take this decision.<\/p>\n<p style=\"text-align: justify;\">The decision boosts company\u2019s plan to move from the engineering intensive development phase to the regular operations of cultivating an excellent product, and improving revenue. Growblox team believes that Poss will play a key role in helping the company to move through transition phase expeditiously and smoothly. Expressing his views, Mr. Poss stated that he is delighted to be a part of Growblox. As a cancer survivor, he strongly believes in the medicinal value of marijuana to treat many fatal diseases.<\/p>\n<p style=\"text-align: justify;\">In last trading session, the stock price of Growblox consolidated and closed at $0.285.<\/p>\n<p style=\"text-align: justify;\"><strong>Sangamo Biosciences, Inc. (NASDAQ:SGMO) Updates On Clinical Plans <\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Sangamo Biosciences, Inc. (NASDAQ:SGMO)<\/strong> <a href=\"http:\/\/finance.yahoo.com\/news\/sangamo-shire-restructure-collaboration-accelerate-110000307.html\">stated<\/a> that they have agreed to extend collaboration and license contract with <strong>Shire PLC (ADR) (NASDAQ:SHPG) <\/strong>to accelerate the development of ZFP Therapeutics for cure of Huntington&#8217;s and Hemophilia \u2018A\u2019 and \u2018B\u2019 disease.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pharmacyte Biotech Inc (OTCMKTS:PMCB) declined 0.52% and closed at $0.0959 in last trading session. The biotech firm is still in clinical stage and it is [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":32925,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[2236,264],"tags":[11676,6989,4941,6186,6990,11643,11642,11641,4940,8593,6185],"stock_ticker":[],"class_list":["post-36699","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","category-health","tag-growblox-sciences-inc","tag-growblox-sciences-inc-otcmktsgblx","tag-nasdaqsgmo","tag-nasdaqshpg","tag-otcmktsgblx","tag-otcmktspmcb","tag-pharmacyte-biotech-inc","tag-pharmacyte-biotech-inc-otcmktspmcb","tag-sangamo-biosciences-inc-nasdaqsgmo","tag-shire-plc-adr","tag-shire-plc-adr-nasdaqshpg","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pharmacyte Biotech Inc (OTCMKTS:PMCB) And Growblox Sciences Inc (OTCMKTS:GBLX) Trades In A Narrow Range - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-and-growblox-sciences-inc-otcmktsgblx-trades-in-a-narrow-range-36699\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharmacyte Biotech Inc (OTCMKTS:PMCB) And Growblox Sciences Inc (OTCMKTS:GBLX) Trades In A Narrow Range - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Pharmacyte Biotech Inc (OTCMKTS:PMCB) declined 0.52% and closed at $0.0959 in last trading session. The biotech firm is still in clinical stage and it is [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-and-growblox-sciences-inc-otcmktsgblx-trades-in-a-narrow-range-36699\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-09-08T12:34:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Greg Folin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Greg Folin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-and-growblox-sciences-inc-otcmktsgblx-trades-in-a-narrow-range-36699#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-and-growblox-sciences-inc-otcmktsgblx-trades-in-a-narrow-range-36699\"},\"author\":{\"name\":\"Greg Folin\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\"},\"headline\":\"Pharmacyte Biotech Inc (OTCMKTS:PMCB) And Growblox Sciences Inc (OTCMKTS:GBLX) Trades In A Narrow Range\",\"datePublished\":\"2015-09-08T12:34:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-and-growblox-sciences-inc-otcmktsgblx-trades-in-a-narrow-range-36699\"},\"wordCount\":330,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-and-growblox-sciences-inc-otcmktsgblx-trades-in-a-narrow-range-36699#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg\",\"keywords\":[\"Growblox Sciences Inc\",\"Growblox Sciences Inc. (OTCMKTS:GBLX)\",\"NASDAQ:SGMO\",\"NASDAQ:SHPG\",\"OTCMKTS:GBLX\",\"OTCMKTS:PMCB\",\"Pharmacyte Biotech Inc\",\"Pharmacyte Biotech Inc (OTCMKTS:PMCB)\",\"Sangamo Biosciences Inc. (NASDAQ:SGMO)\",\"Shire PLC (ADR)\",\"Shire PLC (ADR) (NASDAQ:SHPG)\"],\"articleSection\":[\"Business\",\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-and-growblox-sciences-inc-otcmktsgblx-trades-in-a-narrow-range-36699#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-and-growblox-sciences-inc-otcmktsgblx-trades-in-a-narrow-range-36699\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-and-growblox-sciences-inc-otcmktsgblx-trades-in-a-narrow-range-36699\",\"name\":\"Pharmacyte Biotech Inc (OTCMKTS:PMCB) And Growblox Sciences Inc (OTCMKTS:GBLX) Trades In A Narrow Range - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-and-growblox-sciences-inc-otcmktsgblx-trades-in-a-narrow-range-36699#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-and-growblox-sciences-inc-otcmktsgblx-trades-in-a-narrow-range-36699#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg\",\"datePublished\":\"2015-09-08T12:34:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-and-growblox-sciences-inc-otcmktsgblx-trades-in-a-narrow-range-36699#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-and-growblox-sciences-inc-otcmktsgblx-trades-in-a-narrow-range-36699\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-and-growblox-sciences-inc-otcmktsgblx-trades-in-a-narrow-range-36699#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-and-growblox-sciences-inc-otcmktsgblx-trades-in-a-narrow-range-36699#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharmacyte Biotech Inc (OTCMKTS:PMCB) And Growblox Sciences Inc (OTCMKTS:GBLX) Trades In A Narrow Range\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\",\"name\":\"Greg Folin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"caption\":\"Greg Folin\"},\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharmacyte Biotech Inc (OTCMKTS:PMCB) And Growblox Sciences Inc (OTCMKTS:GBLX) Trades In A Narrow Range - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-and-growblox-sciences-inc-otcmktsgblx-trades-in-a-narrow-range-36699","og_locale":"en_US","og_type":"article","og_title":"Pharmacyte Biotech Inc (OTCMKTS:PMCB) And Growblox Sciences Inc (OTCMKTS:GBLX) Trades In A Narrow Range - Wall Street PR","og_description":"Pharmacyte Biotech Inc (OTCMKTS:PMCB) declined 0.52% and closed at $0.0959 in last trading session. The biotech firm is still in clinical stage and it is [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-and-growblox-sciences-inc-otcmktsgblx-trades-in-a-narrow-range-36699","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2015-09-08T12:34:09+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg","type":"image\/jpeg"}],"author":"Greg Folin","twitter_misc":{"Written by":"Greg Folin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-and-growblox-sciences-inc-otcmktsgblx-trades-in-a-narrow-range-36699#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-and-growblox-sciences-inc-otcmktsgblx-trades-in-a-narrow-range-36699"},"author":{"name":"Greg Folin","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e"},"headline":"Pharmacyte Biotech Inc (OTCMKTS:PMCB) And Growblox Sciences Inc (OTCMKTS:GBLX) Trades In A Narrow Range","datePublished":"2015-09-08T12:34:09+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-and-growblox-sciences-inc-otcmktsgblx-trades-in-a-narrow-range-36699"},"wordCount":330,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-and-growblox-sciences-inc-otcmktsgblx-trades-in-a-narrow-range-36699#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg","keywords":["Growblox Sciences Inc","Growblox Sciences Inc. (OTCMKTS:GBLX)","NASDAQ:SGMO","NASDAQ:SHPG","OTCMKTS:GBLX","OTCMKTS:PMCB","Pharmacyte Biotech Inc","Pharmacyte Biotech Inc (OTCMKTS:PMCB)","Sangamo Biosciences Inc. (NASDAQ:SGMO)","Shire PLC (ADR)","Shire PLC (ADR) (NASDAQ:SHPG)"],"articleSection":["Business","Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-and-growblox-sciences-inc-otcmktsgblx-trades-in-a-narrow-range-36699#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-and-growblox-sciences-inc-otcmktsgblx-trades-in-a-narrow-range-36699","url":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-and-growblox-sciences-inc-otcmktsgblx-trades-in-a-narrow-range-36699","name":"Pharmacyte Biotech Inc (OTCMKTS:PMCB) And Growblox Sciences Inc (OTCMKTS:GBLX) Trades In A Narrow Range - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-and-growblox-sciences-inc-otcmktsgblx-trades-in-a-narrow-range-36699#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-and-growblox-sciences-inc-otcmktsgblx-trades-in-a-narrow-range-36699#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg","datePublished":"2015-09-08T12:34:09+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-and-growblox-sciences-inc-otcmktsgblx-trades-in-a-narrow-range-36699#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-and-growblox-sciences-inc-otcmktsgblx-trades-in-a-narrow-range-36699"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-and-growblox-sciences-inc-otcmktsgblx-trades-in-a-narrow-range-36699#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/biotech.jpg","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-and-growblox-sciences-inc-otcmktsgblx-trades-in-a-narrow-range-36699#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Pharmacyte Biotech Inc (OTCMKTS:PMCB) And Growblox Sciences Inc (OTCMKTS:GBLX) Trades In A Narrow Range"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e","name":"Greg Folin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","caption":"Greg Folin"},"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/36699","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=36699"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/36699\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/32925"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=36699"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=36699"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=36699"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=36699"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}